Cipher Pharmaceuticals Inc (CPH-T) Analyst Research & Price Targets - The Globe and Mail

Earnings Estimates

	Current Qtr03/2026	Next Qtr06/2026	Fiscal Yr12/2026	Fiscal Yr12/2027
Average Estimate	$0.22	$0.30	$1.12	$1.07
Number of Estimates	1	1	2	1
High Estimate	$0.22	$0.30	$1.29	$1.07
Low Estimate	$0.22	$0.30	$0.95	$1.07
Prior Year	$0.14	$0.30	$1.47	$1.12
Growth Rate Est. (year over year)	+57.14%	unch	-23.81%	-4.46%

Earnings History - Surprises*

	Qtr Ending12/2025	Qtr Ending09/2025	Qtr Ending06/2025	Qtr Ending03/2025
Reported	$0.71	$0.29	$0.30	$0.14
Estimate	$0.28	$0.21	$0.24	$0.21
Difference	+0.43	+0.08	+0.06	-0.07
Surprise	+153.57%	+38.10%	+25.00%	-33.33%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

5.00

3 Mths Ago2

5.00

2 Mths Ago2

5.00

1 Mth Ago2

5.00

Current2

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	2	2	2	2
	2	2	2	2
Holds	0	0	0	0

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

Bullish on Pembina Pipeline Corp.

How investors should digest the stock market’s ‘sugar high’

Market Factors: Top picks, sector review for income-heavy utilities sector

The most oversold and overbought stocks on the TSX

The highest-yielding stocks on the TSX, plus risk data

Barlow’s Research Roundup: These stocks are biggest winners from oil price volatility

It’s not just Allbirds - another meme-stock season is on the horizon, Vanda Research says

Why did shares of GFL Environmental drop 10 per cent this week? Take our business and investing news quiz